These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1668 related items for PubMed ID: 17492927

  • 1. The Breast International Group 1-98 trial: big results for women with hormone-sensitive early breast cancer.
    Monnier AM.
    Expert Rev Anticancer Ther; 2007 May; 7(5):627-34. PubMed ID: 17492927
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Update of the BIG 1-98 Trial: where do we stand?
    Joerger M, Thürlimann B.
    Breast; 2009 Oct; 18 Suppl 3():S78-82. PubMed ID: 19914548
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.
    Coates AS, Keshaviah A, Thürlimann B, Mouridsen H, Mauriac L, Forbes JF, Paridaens R, Castiglione-Gertsch M, Gelber RD, Colleoni M, Láng I, Del Mastro L, Smith I, Chirgwin J, Nogaret JM, Pienkowski T, Wardley A, Jakobsen EH, Price KN, Goldhirsch A.
    J Clin Oncol; 2007 Feb 10; 25(5):486-92. PubMed ID: 17200148
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A review of the BIG results: the Breast International Group 1-98 trial analyses.
    Doughty JC.
    Breast; 2008 Jan 10; 17 Suppl 1():S9-S14. PubMed ID: 18279765
    [Abstract] [Full Text] [Related]

  • 13. Towards optimal endocrine therapy for hormone-sensitive breast cancer: initial versus sequential adjuvant aromatase inhibition.
    Spicer J, Ellis P.
    Cancer Lett; 2007 Apr 18; 248(2):165-74. PubMed ID: 16919870
    [Abstract] [Full Text] [Related]

  • 14. Extending the benefits of adjuvant therapy in early HR+ breast cancer.
    Goss PE.
    Breast Cancer Res Treat; 2008 Dec 18; 112 Suppl 1():45-52. PubMed ID: 18785006
    [Abstract] [Full Text] [Related]

  • 15. Letrozole as adjuvant endocrine therapy in postmenopausal women with breast cancer.
    Koeberle D, Thuerlimann B.
    Expert Rev Anticancer Ther; 2006 Jan 18; 6(1):5-10. PubMed ID: 16375638
    [Abstract] [Full Text] [Related]

  • 16. Adjuvant endocrine therapy for postmenopausal women with early breast cancer.
    Ingle JN.
    Clin Cancer Res; 2006 Feb 01; 12(3 Pt 2):1031s-1036s. PubMed ID: 16467121
    [Abstract] [Full Text] [Related]

  • 17. Refining the postmenopausal breast cancer treatment paradigm: the FACE trial.
    Monnier A.
    Expert Rev Anticancer Ther; 2006 Oct 01; 6(10):1355-9. PubMed ID: 17069521
    [Abstract] [Full Text] [Related]

  • 18. The evolving role of letrozole in the adjuvant setting: first results from the large, phase III, randomized trial BIG 1-98.
    Monnier A.
    Breast; 2006 Feb 01; 15 Suppl 1():S21-9. PubMed ID: 16500237
    [Abstract] [Full Text] [Related]

  • 19. Adjuvant therapy with aromatase inhibitors for postmenopausal women with early breast cancer: evidence and ongoing controversy.
    Wheler J, Johnson M, Seidman A.
    Semin Oncol; 2006 Dec 01; 33(6):672-80. PubMed ID: 17145347
    [Abstract] [Full Text] [Related]

  • 20. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses.
    Baum M, Buzdar A, Cuzick J, Forbes J, Houghton J, Howell A, Sahmoud T, ATAC (Arimidex, Tamoxifen Alone or in Combination) Trialists' Group.
    Cancer; 2003 Nov 01; 98(9):1802-10. PubMed ID: 14584060
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 84.